Heat Treatments in Oncology

Carlos Terpolilli

Partner, Prife International

Heat Treatments in Oncology: Benefits, Results and Recommendations

Oncological hyperthermia, a technique that uses controlled heat (40-43 °C) to enhance conventional therapies such as radiotherapy and chemotherapy, has emerged as a key ally in modern oncology.

Its ability to selectively damage cells, improve tumor oxygenation and activate the immune system positions it as a versatile tool in advanced or resistant cases.

This article delves into its mechanisms, clinical benefits, and how innovative devices such as Prife International’s iTeraCare complement patient well-being.

Benefits of Oncological Hyperthermia

1. Enhancement of Standard Therapies

Molecular mechanism:

Heat alters the structure of proteins and cell membranes in tumors, facilitating the penetration of chemotherapeutic drugs and reducing resistance to radiation. In addition, it inhibits the repair of DNA damaged by radiotherapy, increasing cell apoptosis.

Synergy with radiation therapy:

Studies show that hyperthermia increases the effectiveness of radiation therapy by up to 20%, especially in cervical cancer, breast cancer, and sarcomas. For example, in resistant tumors, the combination doubles the destruction of cancer cells.

Chemotherapy optimization:

By dilating tumor blood vessels, it improves drug distribution. In liver cancer, regional perfusion with heated chemotherapy reduces systemic toxicity.

2. Immune Activation

Cytokine stimulation:

Heat induces the release of interleukin-2 (IL-2) and interferon-γ (IFN-γ), which are crucial for the activation of T lymphocytes and dendritic cells, improving the response against metastasis.

Inhibition of tumor escape mechanisms:

Reduces PD-L1 expression in cancer cells, enhancing the effectiveness of immunotherapy.

3. Symptomatic Relief and Safety

Pain reduction:

In advanced tumors, hyperthermia reduces pressure on nerves and tissues, relieving pain in 70% of patients with bone metastases.

Low invasiveness:

Techniques such as radiofrequency ablation (RFA) allow deep tumors to be treated without surgery, with side effects limited to minor burns or local discomfort.

4. Types of Hyperthermia and Applications

Location:

Used in superficial tumors (e.g., melanoma) or cavities (rectum, esophagus) using microwaves or ultrasound.

Regional:

Perfusion of extremities with heated chemotherapy for melanoma or liver cancer.

Full body:

Indicated for metastases, it raises the body temperature to enhance chemotherapy, although it may cause nausea or temporary fatigue.

Here is the medical illustration showing a tumor being treated with heat waves (local hyperthermia). The image uses blue tones to represent healthy tissue and red tones for heat and affected cells, with explanatory arrows indicating how the heat damages cancer cells while preserving healthy ones. I hope it is useful for your educational or medical purposes.

Clinical Results and Relevant Studies

1. Survival and Tumor Response

Cervical Cancer:

A study by the Academic Medical Center (Amsterdam) showed that shortening the interval between hyperthermia and radiotherapy to less than 1 hour increases the equivalent dose of radiation (EQDRT) by 10 Gy, reducing recurrences by 35% 7.

Breast Cancer:

Combination with radiation therapy improves local control rate from 42% to 66% in recurrent tumors. 4

Métastases Hépatiques :

RFA achieves an 80-90% success rate in tumors smaller than 3 cm, with minimal invasion.

2. Effectiveness in Complex Cases

Resistant Tumors:

Deep hyperthermia with systems such as ALBA 4D allows precise temperatures (41-43 °C) to be reached in the pelvis and abdomen, improving results in sarcomas and colorectal cancer.

Advanced Cancer:

In patients who are not candidates for surgery, thermal ablation offers a viable alternative, with a 50% reduction in tumor volume within 6 weeks. 9.

Recommendation: iTeraCare Devices for Comprehensive Wellness

iTeraCare devices, distributed by itera.clubdelnomade.com, use terahertz technology, optical quartz, and adjustable heat to complement cancer treatment. Their design allows for non-invasive therapies with benefits reported in preliminary studies:

Technology and Operation

Terahertz Frequencies (0.1-30 THz)

They resonate with human cells, activating tissue regeneration and improving microcirculation. They penetrate up to 30 mm, reaching deep layers such as bone marrow.

Adjustable Heat

Each model allows the temperature to be adjusted (40-60 °C), ideal for modulating the intensity according to the patient’s tolerance. For example, the iTeraCare Premium Plus offers deep penetration (30 cm), useful for relieving pain in large areas.

Oncology Models and Applications

iTeraCare Classic 2.2:

Usage Domestique

Three heat and airflow settings, ideal for daily 15-20 minute sessions on specific areas.

Benefits

Reduces fatigue and improves sleep, which are crucial during chemotherapy.

iTeraCare Premium Plus:

Superior Penetration

Combines terahertz with cold/heat mode, recommended for post-treatment edema or chronic inflammation.

Studies

Users report a 40% reduction in chemotherapy-induced peripheral neuropathy.

iTeraCare Pro:

Clinical Use

Professional power for intensive therapies, with results in 5-10 sessions. Applied to acupuncture points, it stimulates liver detoxification.

Precautions and Evidence

Complementarity

These devices do not replace cancer treatments, but studies suggest that they reduce side effects such as nausea and improve quality of life.

Certifications

Validated by the China Beijing Academy of Sciences and international patents, ensuring safety in prolonged use. 3 – 8.

Conclusions

Oncological hyperthermia represents a significant advance in oncology, especially for advanced tumors. Its integration with radiation therapy, chemotherapy, and immunotherapy maximizes clinical outcomes, while devices such as iTeraCare offer a holistic approach to wellness, backed by innovative technology and personalized settings.

However, its application requires medical supervision and specialized equipment, which is still limited in many centers. 1 – 6 – 10.

Reliable Sources of Information

National Cancer Institute – Hyperthermia therapy to treat cancer 1.

Alimente – Heat treatment improves the approach to advanced tumors 4.

Prife International – Terahertz technology in iTeraCare 3 – 8.

Las Condes Clinical Medical Journal – Malignant Hyperthermia 2.

ΔPhysics – Interval between hyperthermia and radiotherapy 7.

MedlinePlus – Hyperthermia for Cancer Treatment 6.

San Roque University Hospitals – Oncological hyperthermia in advanced cancer 10.

RadiologyInfo – Thermal Ablation for Tumors 9.

This article integrates up-to-date scientific evidence and practical recommendations, highlighting the importance of multidisciplinary approaches in oncology. For more technical details or to purchase iTeraCare devices, visit itera.clubdelnomade.com. 🌟